Logo 1 Logo 2

Clinical Trial Details

Trial ID: L0454
Source ID: NCT00609544
Associated Drug: Rilonacept
Title: Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Acronym:
Status: WITHDRAWN
Study Results: NO
Results:
Conditions: Chronic Kidney Disease|Anemia
Interventions: DRUG: Rilonacept
Outcome Measures: Primary: Change in blood hemoglobin concentration., Baseline to Week 12 |
Sponsor/Collaborators: Sponsor: Regeneron Pharmaceuticals | Collaborators: Syneos Health
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 0
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date:
Completion Date:
Results First Posted:
Last Update Posted: 2011-04-19
Locations: Alexander City, Alabama, United States|Muscle Shoals, Alabama, United States|Cerritos, California, United States|Long Beach, California, United States|Los Alampios, California, United States|Thousand Palms, California, United States|Colorado Springs, Colorado, United States|Lauderdale Lakes, Florida, United States|Pembroke Pines, Florida, United States|Tampa, Florida, United States|Blue Ridge, Georgia, United States|Jonesboro, Georgia, United States|Portland, Maine, United States|Queens, New York, United States|Mooresville, North Carolina, United States|Shelby, North Carolina, United States|Allentown, Pennsylvania, United States|Harrisburg, Pennsylvania, United States|Orangeburg, South Carolina, United States|Sumter, South Carolina, United States|Barlett, Tennessee, United States|Clarksville, Tennessee, United States|Collierville, Tennessee, United States|Crossville, Tennessee, United States|Memphis, Tennessee, United States|Ogden, Utah, United States|Falls Church, Virginia, United States
URL: https://clinicaltrials.gov/show/NCT00609544